logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Hepatitis B vaccination results in 140 liver transplant recipients.

    Article - En anglais

    Background/Aims 

    Human autologous liver transplantation is possible due to an adequate suppression of the body's immune response.

    This also causes a higher hepatitis infection rate, making hepatitis prevention very important.

    Materials and Methods 

    We describe our experience with hepatitis B virus vaccination in 140 adult liver transplant recipients, transplanted from 1986 to 1994 with more than one year of follow-up.

    Excluded were those who had hepatitis B surface antigens or antibodies to those antigens before the transplant.

    The vaccination schedule was 0-1-2 months with a double dose of recombinant vaccine.

    Results 

    The total response rate (surface antigen antibodies>10 U) was 40% (56/140) ; the rate was 47.7% in men and 26% in women.

    At the end of the study, only 17.1% (24/140) of the patients had antibodies>10 U. The response rate was higher in patients with antibodies to hepatitis B core antigen (66.6%) than in those lacking antibodies (31.7%), and more long lasting (42.4% vs 11.2%). The response rate in 116 patients with booster doses was 12.9%. Six correctly vaccinated patients (4.28%) acquired new hepatitis B virus infections after the operation.

    Conclusions 

    The total response rate in these patients is much lower than in the general population, and there is a rapid decline of titers, probably due to immunosuppression.

    The role ofbooster doses in these patients should be clarified.

    Mots-clés Pascal : Homotransplantation, Foie, Chimioprophylaxie, Hépatite virale B, Virose, Infection, Vaccination, Incidence, Etiologie, Analyse statistique, Rapport coût bénéfice, Prévention, Homme, Transplantation, Chirurgie, Economie santé, Appareil digestif pathologie, Foie pathologie

    Mots-clés Pascal anglais : Homotransplantation, Liver, Chemoprophylaxis, Viral hepatitis B, Viral disease, Infection, Vaccination, Incidence, Etiology, Statistical analysis, Cost benefit ratio, Prevention, Human, Transplantation, Surgery, Health economy, Digestive diseases, Hepatic disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0191746

    Code Inist : 002B25G03. Création : 21/05/1997.